<<
>>

1 -Skeggs L. , Kahn ]. R., Shumway N. . The preparation and function of the hypertensin converting enzyme // J. Exp. Med. 1956. 103. P. 295-9.

2. Bumpus F. M Scwartz H., Page I.

H. Synthesis and pharmacology of the octapeptide angiotonin Science. 1957. 125. P. 886-7.

3. Urata H Kinoshita A., Misono K. S. et al. Identification of a high specific chymase as a major angiotensin -forming enzyme in the human heart // J. biol. Chem. 1990. 265:22. P. 348-57.

4. Okunishi H., Miyazaki M Okamura T. et al. Different distribution of two types of angiotensin -generating enzymes in the aortic wall // Biochem. biophys. Res. Com- mun. 1987. 149. P. 1186-92.

5. lhara M. // Hypertension. 1999. 33. P. 1399-405.

6. Boltary S. P, de Gasparo M Steckeling U. M. et al. Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiologic implications // Front. Neuroendocrinol. 1993. 14. P. 123-71.

7. Mustafa T, Lee J.

H Chai S. Y. et al. Bioactive angiotensin peptides: focus on angiotensin IV // JRAAS. - 2001. 2. P. 205-10.

8. Reaux A., Fournie-Zaluski M. C, Llorens-Cortes C. Angiotensin III: a central regulator of vasopressin release and blood pressure // Trends Endocrinol. Metab. 2001. 12. P. 157-62.

9. Machado R. D Santos R. A., Andrade S. P. Opposing actions of angiotensins on angio- genes // Life Sci. 2000. No 66. P. 67-76.

10. Campbell D. ]. The site of angiotensin production 11J. Hypertension. 1985. 3. P. 199-207.

11. Dzau V. J. Implications of local angiotensin production in cardiovascular physiology and pharmacology // Amer. J. Cardiol. 1987. N 59. P. 59A-65A.

12. De Mello W. C. Is an intracellular rennin-angiotensin system involved in control of cell communications in heart? 11 J.

cardiovasc. Pharmacol. 1994. 23. P. 640-6.

13. Griendling . K., Ushio-Fukai M., Lassegue B. et al. Angiotensin II signaling in vascular smooth muscle. New concepts 11 Hypertension. 1997. 29. P. 366-73.

14. Filipeanu . M Henning R. H Nelemans S. A., de Zeeuw D. Intracellular angiotensin II: from myth to reality? // JRAAS. 2001. 2. P. 219-26.

15. Tuck M. L Sambhi M. P., Levin L. Hyporeninemic hypoaldosteronism in diabetes mel- litus. Studies of the autonomic nervous systems control of rennin release // Diabetes. 1979, 28. P.237-41.

16. Bell G. M Bernstein R. K., Laragh J. H. et al. Increased plasma atrial natriuretic factor and reduced plasma rennin in patients with poorly controlled diabetes mellitus // Clin. Sci. - 1989. 77. - P. 177-82.

\7.Bojestig M Nystrom F, Arnqvist H. J. et al. The renin-angiotensin-aldosteron system is suppressed in adults with type 1 diabetes // JRAAS. 2000. 1. P. 353-6.

18 .Anderson S. Role of local and systemic angiotensin in diabetic renal disease 11 Kidney Int. 1997. 52 (Suppl. 63). P. 107-10.

19. Feener E. P. The rennin-angiotensin system in diabetic cardiovascular complications. In: Diabetes and cardiovascular disease / Ed. by M. T. Johnstone, A. Veves. Totowa, New Jersey: Humana Press, 2001.

20. Trevisan R., Bruttomesso D Vedovato M. et al. Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria // Diabetes. 1998. 47. P. 1347-53.

21. Williams S. B Cusco J. A., Roddy M.-A. et al. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus // J. Amer. Coll. Cardiol. 1996. 27. P. 567-74.

22. Herings R. AL, de Boer A., Strieker . H. et al. Hypoglycemia associated with ise of inhibitors of angoitensin converting enzyme 11 Lancet. 1995. 345. P. 1195.

23. Henriksen E. /., Jakob S., Kinnick T. R. et al. ACE inhibition and glucose transport in insulin resistant muscle: role of bradykinin and nitric oxide // Amer. J. Physiol. 1999. 277. P. 332-6.

24. Folli E, Saad M. J. A., Velloso L. et al. Crosstalk between insulin and angiotensin II signaling systems // Exp. din. Endocrinol. Diabetes. 1999. 107. P. 133-9.

25. Tahmasebi M Puddefoot J. R Inwang E. R. et al. The tissue rennin-angiotensin system in human pancreas // J. Endocrinol. 1999. 161. P. 317-22.

26. Carlsson P. O., Berne G, Jansson L. Angiotensin and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats // Diabetologia. 1998. 41. P. 127-33.

27. Lau T, Carlsson P. O., Leung P. S. Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets // Diabetologia. 2004. 47. P. 240-8.

<< | >>
: .., ... . .: - 26 ,2006 344 .: ., .. 2006

:

  1. :
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - -